ICUI
Undervalued by 84.3% based on the discounted cash flow analysis.
Market cap | $2.36 Billion |
---|---|
Enterprise Value | $3.74 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-1.23 |
Beta | 1.4 |
Outstanding Shares | 24,365,082 |
Avg 30 Day Volume | 232,480 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -79.61 |
---|---|
PEG | -767.78 |
Price to Sales | 1.05 |
Price to Book Ratio | 1.11 |
Enterprise Value to Revenue | 1.65 |
Enterprise Value to EBIT | 78.12 |
Enterprise Value to Net Income | -127 |
Total Debt to Enterprise | 0.44 |
Debt to Equity | 0.77 |
No data
No data
ICU Medical, Inc. is a San Clemente, California-based company with global operations that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical’s products a...